← All decks

Paediatric Surgery

Injectable Bulking Agents in the Treatment of Pediatric Ur

Built from Puri — Pediatric Surgery and Pediatric Urology

What’s inside

8 sections · 53 slides

  1. 01

    The Problem and the Idea

    Why children leak, and how a simple injection can help

    • Urinary incontinence is a symptom, not one disease
    • The unsolved problem: rebuilding the outlet
    • What is a bulking agent?
    • The promising but flawed early results
    • Early promise came with a warning
    • How normal continence works, and where injections help
    • The mechanism: restoring coaptation
    • How an injected bulking agent seals the outlet
    • Who actually benefits?

    9 slides

  2. 02

    Working Up the Child

    Measuring the leak before you treat it

    • Quantify the incontinence first
    • Imaging and pressure studies

    2 slides

  3. 03

    The Other Options

    What injections are competing against

    • Two problems, fewer sphincter fixes
    • Properties of the ideal bulking agent
    • A crucial safety rule: protect the kidneys
    • Slings and reconstruction: effective but demanding
    • The artificial urinary sphincter

    5 slides

  4. 04

    Delivering the Agent

    Categories, regulation, and the four routes

    • How agents are categorised
    • Agents currently FDA-approved in the USA
    • A regulatory caution
    • Four ways to reach the target
    • The four routes for injecting the agent
    • Transurethral and periurethral routes
    • Antegrade routes for the difficult outlet

    7 slides

  5. 05

    The Historical Agents

    PolyTef and collagen: how the field learned its lessons

    • Polytetrafluoroethylene (PolyTef)
    • Cross-linked collagen (Contigen): the old standard
    • What collagen achieved, and its safety debate

    3 slides

  6. 06

    The Modern Agents

    What is available and how well each performs

    • Polydimethylsiloxane (Macroplastique)
    • Macroplastique in children: the results
    • Calcium hydroxylapatite (Coaptite)
    • Durasphere and Bulkamid

    4 slides

  7. 07

    Retired and Experimental Agents

    What has been tried, withdrawn, or is still emerging

    • Silicone membranes and Bioglass
    • Dextranomer/hyaluronan (Deflux, Zuidex)
    • Ethylene vinyl copolymer (Uryx, Tegress)
    • Autologous therapies: using the patient's own cells
    • The frontier: engineered muscle

    5 slides

  8. 08

    Where This Leaves Us

    Honest limits and cautious optimism

    • Conclusion: a useful but imperfect tool
    • Read the evidence with healthy skepticism
    • Key takeaways
    • References (1/5)
    • References (2/5)
    • References (3/5)
    • References (4/5)
    • References (5/5)
    • Pediatric Surgery and Pediatric Urology

    9 slides